The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi-experimental study.
adverse drug events
home care intervention
hospital admissions
nursing home intervention
quasi-experimental study design
Journal
Nursing open
ISSN: 2054-1058
Titre abrégé: Nurs Open
Pays: United States
ID NLM: 101675107
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
revised:
21
10
2021
received:
12
04
2021
accepted:
16
11
2021
pubmed:
4
12
2021
medline:
31
3
2022
entrez:
3
12
2021
Statut:
ppublish
Résumé
To estimate the cost-effectiveness of an intervention facilitating the early detection of adverse drug events through the means of health professional training and the application of a digital screening tool. Multi-centred non-randomized controlled trial from August 2018 to March 2020 including 65 nursing homes or home care providers. We aim to estimate the effect of the intervention on the rate of adverse drug events as primary outcome through a quasi-experimental empirical study design. As secondary outcomes, we use hospital admissions and falls. All outcomes will be measured on patient-month level. Once the causal effect of the intervention is estimated, cost-effectiveness will be calculated. For cost-effectiveness, we include all patient costs observed by the German statutory health insurance. The results of this study will inform about the cost-effectiveness of the optimized drug supply intervention and provide evidence for potential reimbursement within the German statutory health insurance system.
Identifiants
pubmed: 34859616
doi: 10.1002/nop2.1146
pmc: PMC8859083
doi:
Types de publication
Controlled Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1477-1485Informations de copyright
© 2021 The Authors. Nursing Open published by John Wiley & Sons Ltd.
Références
J Am Med Inform Assoc. 2014 May-Jun;21(3):547-57
pubmed: 24222671
Clin Interv Aging. 2008;3(2):383-9
pubmed: 18686760
Drugs Real World Outcomes. 2015 Sep;2(3):249-259
pubmed: 27747571
Unfallchirurg. 2000 Sep;103(9):741-8
pubmed: 11039294
JAMA. 2015 Nov 3;314(17):1818-31
pubmed: 26529160
BMJ. 2010 Mar 23;340:c869
pubmed: 20332511
World Health Organ Tech Rep Ser. 1972;498:1-25
pubmed: 4625548
J Am Geriatr Soc. 1994 Jul;42(7):774-8
pubmed: 8014355
Eur J Clin Pharmacol. 2017 May;73(5):601-608
pubmed: 28093640
Drugs Aging. 2018 Feb;35(2):145-152
pubmed: 29411310
Eval Rev. 2016 Jun;40(3):167-198
pubmed: 27553034
Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):719-27
pubmed: 23585247
J Am Geriatr Soc. 2015 Nov;63(11):2227-46
pubmed: 26446832
BMC Health Serv Res. 2011 May 29;11:134
pubmed: 21619706
Am J Geriatr Pharmacother. 2006 Mar;4(1):36-41
pubmed: 16730619
Clin Geriatr Med. 2012 May;28(2):173-86
pubmed: 22500537
Br J Gen Pract. 2012 Dec;62(605):e821-6
pubmed: 23211262
Geriatr Nurs. 2010 Sep-Oct;31(5):368-74
pubmed: 20832910
Nurs Open. 2022 Mar;9(2):1477-1485
pubmed: 34859616
Clin Pharmacol Ther. 2009 Jan;85(1):86-8
pubmed: 19037203
BMJ. 2013 Nov 28;347:f7033
pubmed: 24286985
Clin Epidemiol. 2018 Mar 12;10:289-298
pubmed: 29559811
J Am Geriatr Soc. 2014 Dec;62(12):2261-72
pubmed: 25516023
Drugs Aging. 2016 Jan;33(1):45-51
pubmed: 26659732